Provider beliefs on the Barriers and Facilitators to Prescription Monitoring Programs and Mandated Use

References

• Ashrafioun, L., Edwards, P. C., Bohnert, A. S., & Ilgen, M. A. (2014). Nonmedical use of pain medications in dental patients. The American Journal of Drug and Alcohol Abuse, 40(4), 312–316. doi:10.3109/00952990.2014.930152
   PubMed Web of Science ®Google Scholar
• Bachhuber, M. A., Saloner, B., LaRochelle, M., Merlin, J. S., Maughan, B. C., Polsky, D., … Murphy, S. M. (2018). Physician time burden associated with querying prescription drug monitoring programs. Pain Medicine, 19(10), 1952. doi:10.1093/pm/pny053
   PubMed Web of Science ®Google Scholar
• Blum, C. J., Nelson, L. S., & Hoffman, R. S. (2016). A survey of physicians' perspectives on the New York State Mandatory Prescription Monitoring Program (ISTOP). Journal of Substance Abuse Treatment, 70, 35–43. doi:10.1016/j.jsat.2016.07.013
   PubMed Web of Science ®Google Scholar
• Click, I. A., Basden, J. A., Bohannon, J. M., Anderson, H., & Tudiver, F. (2018). Opioid prescribing in rural family practices: A qualitative study. Substance Use & Misuse, 53(4), 533–540. doi:10.1080/10826084.2017.1342659
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (2017). Integrating and Expanding Prescription Drug Monitoring Program Data: Lessons From Nine States. Atlanta, GA: Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. Retrieved January 15, 2019 from https://www.cdc.gov/drugoverdose/pdf/pehriie_report-a.pdf.
   Google Scholar
• Christianson, H., Driscoll, E., & Hull, A. (2018). Alaska nurse practitioners' barriers to use of prescription drug monitoring programs. Journal of the American Association of Nurse Practitioners, 30(1), 35–42. doi:10.1097/JXX.0000000000000002
   PubMed Web of Science ®Google Scholar
• Cochran, G., Field, C., Lawson, K., & Erickson, C. (2013). Pharmacists' knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: A survey of Utah and Texas pharmacists. Journal of Pharmaceutical Health Services Research, 4(2), 71–79. doi:10.1111/jphs.12013
   Google Scholar
• Denisco, R. C., Kenna, G. A., O’Neil, M. G., Kulich, R. J., Moore, P. A., Kane, W. T., … Katz, N. P. (2011). Prevention of prescription opioid abuse: The role of the dentist. The Journal of the American Dental Association, 142(7), 800–810. doi:10.14219/jada.archive.2011.0268
   PubMed Web of Science ®Google Scholar
• Deyo, R. A., Irvine, J. M., Hallvik, S. E., Hildebran, C., Beran, T., Millet, L. M., & Marino, M. (2015). Leading a horse to water: Facilitating registration and use of a prescription drug monitoring program. The Clinical Journal of Pain, 31(9), 782–787. doi:10.1097/AJP.0000000000000180
   PubMed Web of Science ®Google Scholar
• Fass, J. A., & Hardigan, P. C. (2011). Attitudes of Florida Pharmacists Toward Implementing a State Prescription Drug Monitoring Program for Controlled Substances. Journal of Managed Care Pharmacy, 17(6), 430–438. doi:10.18553/jmcp.2011.17.6.430
   PubMed Web of Science ®Google Scholar
• Feldman, L., Williams, K. S., Coates, J., & Knox, M. (2011). Awareness and utilization of a prescription monitoring program among physicians. Journal of Pain & Palliative Care Pharmacotherapy, 25(4), 313–317. doi:10.3109/15360288.2011.606292
   PubMedGoogle Scholar
• Fendrich, M., Bryan, J. K., & Hooyer, K. (2018). Prescription drug monitoring programs and pharmacist orientation toward dispensing controlled substances. Substance Use & Misuse, 53(8), 1324–1330. doi:10.1080/10826084.2017.1408650
   PubMed Web of Science ®Google Scholar
• Ferries, E. A., Gilson, A. M., Aparasu, R. R., Chen, H., Johnson, M. L., & Fleming, M. L. (2017). The prevalence of and factors associated with receiving concurrent controlled substance prescriptions. Substance Use & Misuse, 52(12), 1639–1645. doi:10.1080/10826084.2017.1298617
   PubMed Web of Science ®Google Scholar
• Fink, D. S., Schleimer, J. P., Sarvet, A., Grover, K. K., Delcher, C., Castillo-Carniglia, A., … Cerdá, M. (2018). Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: A systematic review. Annals of Internal Medicine, 168(11), 783–790. doi:10.7326/M17-3074
   PubMed Web of Science ®Google Scholar
• Fleming, M. L., Bapat, S. S., & Varisco, T. J. (2018). Using the theory of planned behavior to investigate community pharmacists’ beliefs regarding engaging patients about prescription drug misuse. Research in Social and Administrative Pharmacy, 15(8), 992–999. doi:10.1016/j.sapharm.2018.10.027
   PubMed Web of Science ®Google Scholar
• Fleming, M. L., Barner, J. C., Brown, C. M., Shepherd, M. D., Strassels, S., & Novak, S. (2014a). Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database. Research in Social and Administrative Pharmacy, 10(2), 285–296. doi:10.1016/j.sapharm.2013.05.009
   PubMed Web of Science ®Google Scholar
• Fleming, M. L., Barner, J. C., Brown, C. M., Shepherd, M. D., Strassels, S. A., & Novak, S. (2014b). Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. Journal of the American Pharmacists Association, 54(3), 241–250. doi:10.1331/JAPhA.2014.13168
   PubMed Web of Science ®Google Scholar
• Freeman, P. R., Curran, G. M., Drummond, K. L., Martin, B. C., Teeter, B. S., Bradley, K., … Edlund, M. J. (2018). Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study. Research in Social and Administrative Pharmacy, 15(6), 754–760. doi:10.1016/j.sapharm.2018.09.007
   PubMed Web of Science ®Google Scholar
• Garcia, A. A., Rosen, K. D., Finley, E., & Potter, J. S. (2017). A systematic review of barriers and facilitators to implementing a prescription drug monitoring program. Drug and Alcohol Dependence, 171, e69. doi:10.1016/j.drugalcdep.2016.08.198
   Google Scholar
• Gavaza, P., Fleming, M., & Barner, J. C. (2014). Examination of psychosocial predictors of Virginia pharmacists' intention to utilize a prescription drug monitoring program using the theory of planned behavior. Research in Social and Administrative Pharmacy, 10(2), 448–458. doi:10.1016/j.sapharm.2013.06.011
   PubMed Web of Science ®Google Scholar
• Governor’s Communication Office press release (2013). One year in, landmark prescription drug bill shows huge impact [Press release]. Retrieved from http://migration.kentucky.gov/newsroom/governor/20130725hb1.htm
   Google Scholar
• Hagemeier, N. E., Gray, J. A., & Pack, R. P. (2013). Prescription drug abuse: A comparison of prescriber and pharmacist perspectives. Substance Use & Misuse, 48(9), 761–768. doi:10.3109/10826084.2013.787101
   PubMed Web of Science ®Google Scholar
• Hagemeier, N. E., Murawski, M. M., Lopez, N. C., Alamian, A., & Pack, R. P. (2014). Theoretical exploration of Tennessee community pharmacists' perceptions regarding opioid pain reliever abuse communication. Research in Social and Administrative Pharmacy, 10(3), 562–575. 10.1016/j.sapharm.2013.07.004
   PubMed Web of Science ®Google Scholar
• Hildebran, C., Cohen, D. J., Irvine, J. M., Foley, C., O'Kane, N., Beran, T., & Deyo, R. A. (2014). How clinicians use prescription drug monitoring programs: A qualitative inquiry. Pain Medicine, 15(7), 1179–1186. doi:10.1111/pme.12469
   PubMed Web of Science ®Google Scholar
• Hartung, D. M., Hall, J., Haverly, S. N., Cameron, D., Alley, L., Hildebran, C., … Cohen, D. (2018). Pharmacists’ role in opioid safety: A focus group investigation. Pain Medicine, 19(9), 1799–1806. 10.1093/pm/pnx139
   PubMed Web of Science ®Google Scholar
• Injury Prevention Research Center, The University of Iowa College of Public Health (2017, August 1). The prescription opioid crisis: Policy and program recommendations to reduce opioid overdose and deaths in Iowa. Retrieved from http://www.public-health.uiowa.edu/iprc/wp-content/uploads/2017/10/UIIPRC_Opioid_Report-_17.web_.pdf
   Google Scholar
• Iowa Board of Pharmacy (2018, July 20). Registration with prescription monitoring program (PMP) mandatory for all Iowa controlled substances act registrants. Retrieved January 17, 2019 from https://pharmacy.iowa.gov/press-release/2018-07-20/registration-prescription-monitoring-program-pmp-mandatory-all-iowa
   Google Scholar
• Iowa Governor’s Office of Drug Control Policy (2016, September). Opioid abuse in Iowa Rx to heroin & beyond. Retrieved from https://odcp.iowa.gov/sites/default/files/documents/2016/09/opioid_abuse_in_iowa_september_2016_9-6-16.pdf
   Google Scholar
• Irvine, J. M., Hallvik, S. E., Hildebran, C., Marino, M., Beran, T., & Deyo, R. A. (2014). Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians. The Journal of Pain, 15(7), 747–755. doi:10.1016/j.jpain.2014.04.003
   PubMed Web of Science ®Google Scholar
• LeMire, S. D., Martner, S. G., & Rising, C. (2012). Advanced practice nurses' use of prescription drug monitoring program information. The Journal for Nurse Practitioners, 8(5), 383–388. doi:10.1016/j.nurpra.2012.02.016
   Google Scholar
• McCauley, J. L., Gilbert, G. H., Cochran, D. L., Gordan, V. V., Leite, R. S., Fillingim, R. B., & Brady, K. T. (2019). Prescription drug monitoring program use: National dental PBRN results. JDR Clinical and Translational Research, 4(2), 178–186. doi:10.1177/2380084418808517
   PubMed Web of Science ®Google Scholar
• McCauley, J. L., Hyer, J. M., Ramakrishnan, V. R., Leite, R., Melvin, C. L., Fillingim, R. B., … Brady, K. T. (2016). Dental opioid prescribing and multiple opioid prescriptions among dental patients: Administrative data from the South Carolina prescription drug monitoring program. The Journal of the American Dental Association, 147(7), 537–544. doi:10.1016/j.adaj.2016.02.017
   PubMed Web of Science ®Google Scholar
• McCauley, J. L., Leite, R. S., Melvin, C. L., Fillingim, R. B., & Brady, K. T. (2016). Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention. Substance Abuse, 37(1), 9–14. doi:10.1080/08897077.2015.1127870
   PubMed Web of Science ®Google Scholar
• National Association of Boards of Pharmacy (2015). Stakeholders release consensus document on the challenges and “Red Flag” warning signs related to prescribing and dispensing controlled substances. Retrieved from https://nabp.pharmacy/wp-content/uploads/2016/07/Red-Flags-Controlled-Substances-03-2015.pdf
   Google Scholar
• Norwood, C. W., & Wright, E. R. (2016). Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment. Research in Social and Administrative Pharmacy, 12(2), 257–266. doi:10.1016/j.sapharm.2015.05.008
   PubMed Web of Science ®Google Scholar
• Perrone, J., DeRoos, F. J., & Nelson, L. S. (2012). Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012. Journal of Medical Toxicology, 8(4), 341–352. 10.1007/s13181-012-0250-2
   PubMedGoogle Scholar
• Poon, S. J., Greenwood-Ericksen, M. B., Gish, R. E., Neri, P. M., Takhar, S. S., Weiner, S. G., … Landman, A. B. (2016). Usability of the Massachusetts Prescription Drug Monitoring Program in the Emergency Department: A Mixed-methods Study. Academic Emergency Medicine, 23(4), 406–414. doi:10.1111/acem.12905
   PubMed Web of Science ®Google Scholar
• Prescription Drug Monitoring Program Center of Excellence at Brandeis (2014a, September). Briefing on PDMP effectiveness. Retrieved from http://www.pdmpassist.org/pdf/Resources/Briefing%20on%20PDMP%20Effectiveness%203rd%20revision.pdf
   Google Scholar
• Prescription Drug Monitoring Program Center of Excellence at Brandeis (2014b). February). Mandating PDMP participation by medical providers: Current status and experience in selected states. Retrieved from https://www.ncjrs.gov/pdffiles1/bja/247134.pdf
   Google Scholar
• Radomski, T. R., Bixler, F. R., Zickmund, S. L., Roman, K. M., Thorpe, C. T., Hale, J. A., … Gellad, W. F. (2018). Physicians' perspectives regarding prescription Drug Monitoring Program use within the Department of Veterans Affairs: A multi-state qualitative study. Journal of General Internal Medicine, 33(8), 1253–1259. doi:10.1007/s11606-018-4374-1
   PubMed Web of Science ®Google Scholar
• Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in drug and opioid overdose deaths–United States, 2000-2014. Mmwr. Morbidity and Mortality Weekly Report, 64(50/51), 1378–1382. doi:10.15585/mmwr.mm6450a3
   PubMed Web of Science ®Google Scholar
• Rutkow, L., Smith, K. C., Lai, A. Y., Vernick, J. S., Davis, C. S., & Alexander, G. C. (2017). Prescription drug monitoring program design and function: A qualitative analysis. Drug and Alcohol Dependence, 180, 395–400. doi:10.1016/j.drugalcdep.2017.08.040
   PubMed Web of Science ®Google Scholar
• Rutkow, L., Turner, L., Lucas, E., Hwang, C., & Alexander, G. C. (2015). Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Affairs, 34(3), 484–492. doi:10.1377/hlthaff.2014.1085
   PubMed Web of Science ®Google Scholar
• Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018). Overdose Deaths involving opioids, cocaine, and psychostimulants – United States, 2015–2016. Mmwr. Morbidity and Mortality Weekly Report, 67(12), 349–358. doi:10.15585/mmwr.mm6712a1
   PubMed Web of Science ®Google Scholar
• Sun, B. C., Lupulescu-Mann, N., Charlesworth, C. J., Kim, H., Hartung, D. M., Deyo, R. A., & John McConnell, K. (2018). Variations in prescription drug monitoring program use by prescriber specialty. Journal of Substance Abuse Treatment, 94, 35–40. doi:10.1016/j.jsat.2018.08.006
   PubMed Web of Science ®Google Scholar
• The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) at Brandeis University (2019, January). PDMP mandatory query by prescribers and dispensers. Retrieved from http://www.pdmpassist.org/pdf/Mandatory_Query_20190115.pdf
   Google Scholar
• The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) at Brandeis University (2018, November). Access to PDMP data via integration with: Health information exchanges (HIE), electronic health records (EHR), and/or pharmacy dispensing systems (PDS). Retrieved from http://www.pdmpassist.org/pdf/PDMP_Integration_Status_20181128.pdf Accessed 15 January, 2019
   Google Scholar
• The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) at Brandeis University (2019, January). PDMP mandatory enrollment of prescribers and dispensers. Retrieved from http://www.pdmpassist.org/pdf/Mandatory_Enrollment_20190115.pdf
   Google Scholar
• Vijayaraghavan, M., Penko, J., Guzman, D., Miaskowski, C., & Kushel, M. B. (2011). Primary care providers' judgments of opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. Journal of General Internal Medicine, 26(4), 412–418. doi:10.1007/s11606-010-1555-yrand
   PubMed Web of Science ®Google Scholar
• Wen, H., Schackman, B. R., Aden, B., & Bao, Y. (2017). States with prescription drug monitoring mandates saw a reduction in opioids prescribed to medicaid enrollees. Health Affairs, 36(4), 733–741. doi:10.1377/hlthaff.2016.1141
   PubMed Web of Science ®Google Scholar